कृपया अन्य खोज का प्रयास करें
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company’s products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202, which is in Phase I/II clinical trial for the treatment of Duchenne muscular dystrophy. It also develops RGX-121 for the treatment of mucopolysaccharidosis type II that is in Phase III clinical trial; RGX-111 for treating mucopolysaccharidosis type I; RGX-181 for the treatment of late infantile neuronal ceroid lipofuscinosis type II; and RGX-381 to treat the ocular manifestations of CLN2 disease. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Kenneth T. Mills | 47 | 2009 | President, CEO & Director |
Allan M. Fox | 74 | 2009 | Chairman of the Board |
David C. Stump | 72 | 2015 | Independent Director |
Daniel Tassé | 62 | 2016 | Independent Director |
Jean E. Bennett | 67 | 2021 | Independent Director |
Judith Lea Swain | 74 | - | Member of Scientific Advisor |
Argeris N. Karabelas | 71 | 2015 | Lead Independent Director |
Inder Mohan Verma | 75 | - | Member of Scientific Advisor |
Alexandra Glucksmann | 64 | 2018 | Independent Director |
George V. Migausky | 69 | 2021 | Independent Director |
Jennifer L. Zachary | 45 | 2022 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है